证券代码：688017 证券简称：绿的谐波 公告编号：2025-028 苏州绿的谐波传动科技股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/6/18 | 2025/6/19 | 2025/6/19 | 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025年 5月 20 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本183,212,735股为基数，每股派发现 （1）无限售条件流通股的红利委托中国结算上海分公司通过其资金清算系统 向股权登记日上海证券交易所收市后登记在册并在上海证券交易所各会员办理了 指定交易的股东派发。已办理指定交易的投 ...

减持计划的实施结果情况 2025 年 2 月 18 日，公司在上海证券交易所网站（www.sse.com.cn）披露了 《苏州绿的谐波传动科技股份有限公司董事集中竞价减持股份计划公告》（公告 编号：2025-008），李谦先生因自身资金需求，拟通过集中竞价交易或大宗交易 的方式减持其所持有的公司股份合计不超过 450,000 股，本次减持比例合计不超 过公司总股本的 0.25%，减持期间为 2025 年 3 月 11 日至 2025 年 6 月 10 日。 证券代码：688017 证券简称：绿的谐波 公告编号：2025-027 苏州绿的谐波传动科技股份有限公司 董事减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 董监高持有的基本情况 本次减持计划实施前，苏州绿的谐波传动科技股份有限公司（以下简称"公 司"）股东李谦先生持有公司股份 1,806,767 股，占公司总股本比例为 0.99%。 上述股份均为公司首次公开发行前取得股份，并于 2023 年 8 月 28 日上市流通。 | ...

证券代码：688017 证券简称：绿的谐波 公告编号：2025-027 苏州绿的谐波传动科技股份有限公司 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： ? 董监高持有的基本情况 本次减持计划实施前，苏州绿的谐波传动科技股份有限公司（以下简称"公 司"）股东李谦先生持有公司股份 1,806,767 股，占公司总股本比例为 0.99%。 上述股份均为公司首次公开发行前取得股份，并于 2023 年 8 月 28 日上市流通。 ? 减持计划的实施结果情况 《苏州绿的谐波传动科技股份有限公司董事集中竞价减持股份计划公告》（公告 编号：2025-008），李谦先生因自身资金需求，拟通过集中竞价交易或大宗交易 的方式减持其所持有的公司股份合计不超过 450,000 股，本次减持比例合计不超 过公司总股本的 0.25%，减持期间为 2025 年 3 月 11 日至 2025 年 6 月 10 日。 公司于近日收到李谦先生的《关于股份减持结果的告知函》，现将相关减持 计划实施结果具体公告如下：截至 2025 年 ...

证券代码：688017 证券简称：绿的谐波 公告编号：2025-027 苏州绿的谐波传动科技股份有限公司 董事减持股份结果公告 重要内容提示： 董监高持有的基本情况 本次减持计划实施前，苏州绿的谐波传动科技股份有限公司（以下简称"公 司"）股东李谦先生持有公司股份 1,806,767 股，占公司总股本比例为 0.99%。 上述股份均为公司首次公开发行前取得股份，并于 2023 年 8 月 28 日上市流通。 减持计划的实施结果情况 2025 年 2 月 18 日，公司在上海证券交易所网站（www.sse.com.cn）披露了 《苏州绿的谐波传动科技股份有限公司董事集中竞价减持股份计划公告》（公告 编号：2025-008），李谦先生因自身资金需求，拟通过集中竞价交易或大宗交易 的方式减持其所持有的公司股份合计不超过 450,000 股，本次减持比例合计不超 过公司总股本的 0.25%，减持期间为 2025 年 3 月 11 日至 2025 年 6 月 10 日。 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 | ...

Conference Overview - The 2025 China Robot Intelligence Conference will be held from June 13 to 15, 2025, in Haidian District, Beijing, focusing on "Technology Leading New Quality Productivity" [2] - The conference is organized by the Robotics Intelligence Professional Committee of the Chinese Automation Society, with participation from several prestigious institutions [2] - Expected attendance is over 200 people, including more than 60 national-level talents, featuring over 20 high-level reports [2] Conference Schedule - Keynote speeches will be delivered by prominent academicians, including Qian Feng and Wang Yaonan, on June 14 [6] - Parallel forums will cover various topics such as Control, Cognition, Bionic Robot Systems, Decision Making, and AI for Science, with multiple expert speakers [6][7] Registration and Sponsorship - Registration can be completed online, with a deadline for hotel reservations set for June 5, 2025 [9][13] - Sponsorship opportunities are available at four levels: Diamond (100,000), Platinum (50,000), Gold (30,000), and Silver (10,000) [17] - Different sponsorship levels offer various benefits, including free registrations, exhibition space, and promotional opportunities [21][18] Industry Participation - The conference will feature participation from various sectors, including industrial robots, service robots, medical robots, humanoid robots, and embodied intelligence companies [23][24] - Notable companies in the industrial robot sector include Estun Automation and Efort Robotics, while medical robot companies include Yuanhua Intelligent and Tianzhihang [23][24]

Key Points - The main point of the news is the net inflow of capital in the Shanghai and Shenzhen stock markets, with a total of 1.074 billion yuan, indicating a positive sentiment among investors [1] - In the Sci-Tech Innovation Board, there was a net inflow of 145 million yuan, with 281 stocks experiencing net inflows and 304 stocks facing net outflows [1] - The top three stocks with the highest net inflow of capital were Cambrian Technology (34.874 million yuan), SMIC (8.020 million yuan), and Green Harmony (7.596 million yuan) [2] - The stock with the highest net outflow was Lanqi Technology, which saw a net outflow of 15.6 million yuan [1] - A total of 52 stocks experienced continuous net inflows for more than three trading days, with BeiGene leading at 13 consecutive days [2] - Conversely, 108 stocks had continuous net outflows, with Science and Technology leading at 13 consecutive days [2] Capital Flow Analysis - The total net inflow of capital in the market was 1.074 billion yuan, with the Sci-Tech Innovation Board contributing 145 million yuan [1] - Among the stocks with significant net inflows, Cambrian Technology led with 34.874 million yuan, followed by SMIC and Green Harmony [2] - The stocks with the highest net outflows included Lanqi Technology, which had a net outflow of 15.6 million yuan, and others like Zhong Unmanned Aerial Vehicle and Zejing Pharmaceutical [1] Continuous Capital Flow - 52 stocks had continuous net inflows for over three trading days, with BeiGene at the forefront with 13 days [2] - 108 stocks experienced continuous net outflows, with Science and Technology also at 13 days [2]

Investment Rating - The report maintains an "Outperform" rating for the industry [4][7]. Core Views - The integration of artificial intelligence and logistics is being actively promoted in China, with significant developments in humanoid robots and the upcoming launch of Tesla's Robotaxi pilot program [1][2][14]. - The report highlights the rapid advancements in AI infrastructure and the potential for increased efficiency in logistics and other sectors through AI applications [2][24]. Summary by Sections Industry Dynamics - The humanoid robot F.03 from Figure has officially started walking as of May 27, 2025 [15]. - The establishment of the Embodied Intelligence Data Alliance in Shanghai on May 29, 2025, aims to enhance data services in various sectors [16]. - Tesla plans to launch a Robotaxi pilot service in Austin, Texas, in June 2025, initially deploying 10 Model Y vehicles [14][29]. Government News - The National Postal Bureau is accelerating the application of AI in the postal industry, aiming to create benchmark products [24]. - The Zhejiang Province has released implementation opinions to promote intelligent computing cloud innovation from 2025 to 2027 [28]. Company Dynamics - Double Lin Co. plans to raise no more than 1.5 billion yuan through a private placement for various projects [28]. - Zhiyuan Robotics has secured a new round of investment led by a state-owned capital investment platform [21]. Key Companies and Investment Outlook - The report identifies key companies in the humanoid robot sector, including suppliers of joints, sensors, and other components, emphasizing the importance of strong market positions [3][6]. - Companies such as Green Harmonic, Huichuan Technology, and others are highlighted for their potential growth in the AI infrastructure sector [7][31]. Market Performance - The report provides a detailed performance review of key companies, noting fluctuations in stock prices and market trends over recent weeks [13][31].

Core Viewpoint - The humanoid robot industry is expected to experience strong growth, with a significant demand for harmonic reducers projected by 2027, leading to potential supply shortages [1][2]. Group 1: Industry Growth and Demand - The traditional industrial sector, which includes industrial robots, is expected to demand approximately 2 million units in 2024, with an annual growth rate of 8-10% [2]. - The average usage of harmonic reducers in humanoid robots is over 10 units per machine, with global humanoid robot sales potentially exceeding 500,000 units by 2027, resulting in a demand for 6 million harmonic reducers [2]. - Total demand, combining traditional and humanoid robots, could reach 8.72 million units by 2027 [2]. Group 2: Supply and Capacity - By 2025, global effective production capacity for harmonic reducers is estimated at 5 million units, with a utilization rate of less than 50% [2]. - A demand surge in 2027 may create a supply gap exceeding 2 million units, with the long-term global market for harmonic reducers potentially exceeding 100 billion [2]. Group 3: Competitive Landscape - The competitive landscape is rapidly evolving, with domestic companies leading the incremental demand for humanoid robots [3]. - In 2024, Harmonic Drive (哈默纳科) is projected to hold a 58% global market share, while domestic company Green Harmonic (绿的) leads the first tier with a 15% share [3]. - New entrants are focusing on the humanoid sector, emphasizing manufacturers with strong technical capabilities and customer advantages [3]. Group 4: Pricing and Cost Structure - The mainstream price for harmonic reducers ranges from 1,000 to 2,000 per unit, with a slight downward trend expected [3]. - The manufacturing cost of harmonic reducers accounts for over 50% of the total cost, indicating significant potential for cost reduction through scale [3].

Core Viewpoint - The article highlights the rapid advancements and growing interest in the robotics industry, particularly in humanoid robots, as evidenced by recent competitions that showcase both technological breakthroughs and existing challenges [3][4]. Industry Overview - The robotics industry is segmented into three main areas: upstream core components, midstream machine manufacturing and system integration, and downstream end applications [6]. - Upstream components include servo systems, reducers, controllers, AI chips, and sensors, which are critical for robot performance. For instance, Huichuan Technology holds a 32.5% market share in the domestic servo system market [7][8]. - Midstream manufacturing includes industrial and service robots, with companies like Estun and Ecovacs leading in market share [10]. - Downstream applications focus on integrating robots into various industrial processes, enhancing labor efficiency and manufacturing precision [11]. Regional Development - Shenzhen is identified as the "robotics capital" of China, with over 74,032 robotics companies and a total industry output surpassing 200 billion yuan in 2024, marking a 12.58% increase [13]. - Other cities like Beijing, Shanghai, Nanjing, Suzhou, and Hefei are also emerging as significant players in the robotics sector, each with unique strengths such as intelligent algorithms, application expansion, and voice interaction technology [19][20][21][23]. Market Potential - The global humanoid robot market is projected to grow from approximately $1.017 billion in 2024 to $15 billion by 2030, with a compound annual growth rate exceeding 56% [26]. - China is positioned as the largest market for robotics applications, driving the industry's growth and contributing to economic development and industrial upgrades [26].

Core Viewpoint - The Chinese innovative pharmaceutical industry is transitioning from imitation to original innovation, with significant growth in outbound transactions and a promising future for internationalization [4] Group 1: Market Performance - As of May 29, 2025, the Sci-Tech Innovation Board 100 Index (000698) rose by 1.63%, with notable increases in constituent stocks such as Borui Pharmaceutical (688166) up 9.66% and Zhixiang Jintai (688443) up 6.57% [3] - The Sci-Tech 100 Index ETF (588030) increased by 1.60%, with a latest price of 0.95 yuan and a turnover rate of 1.16%, totaling 71.56 million yuan in transactions [3] - Over the past year, the average daily transaction volume of the Sci-Tech 100 Index ETF reached 424 million yuan, ranking first among comparable funds [3] Group 2: Fund Growth and Performance - The Sci-Tech 100 Index ETF saw a significant increase in scale, growing by 94.45 million yuan over the past two weeks, ranking second among comparable funds [4] - In the past week, the ETF's shares increased by 99 million, also ranking first among comparable funds [5] - The ETF has experienced a net inflow of 71.08 million yuan over the last five trading days, indicating strong investor interest [5] Group 3: Financial Metrics - As of May 28, 2025, the Sci-Tech 100 Index ETF's net value increased by 19.94% over the past year, with a maximum monthly return of 27.67% since inception [5] - The ETF's management fee is 0.15% and the custody fee is 0.05%, making it the lowest among comparable funds [5] - The tracking error for the ETF over the past six months is 0.016%, indicating high tracking precision compared to similar funds [5] Group 4: Industry Insights - From the beginning of 2025 to the present, the total outbound transaction amount for innovative drugs has reached 45.5 billion USD, with upfront payments totaling 2.2 billion USD, suggesting a record year ahead [4] - Most domestic innovative drugs currently in the U.S. are in clinical stages, with significant potential for future growth as they progress towards commercialization [4]